TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35093596

Group type: EXPERIMENTAL
Intervention: CSEA+AI
Number of subjects: 360

Group type: COMPARATOR
Intervention: CSEA
Number of subjects: 360

Group type: COMPARATOR
Intervention: AI
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control
Number of subjects: 360
Study: 33858696

Group type: EXPERIMENTAL
Intervention: Stress taper fixation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Bicortical fixation
Number of subjects: 14
Study: 35045396

Group type: EXPERIMENTAL
Intervention: Yoga intervention (n = 23), 45 minutes for 12 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 43
Study: 32114877

Group type: EXPERIMENTAL
Intervention: Otago Exercise Program (OEP)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Otago Exercise Program with Motivational Interviewing (OEP with MI)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 175
Study: 36001070

Group type: EXPERIMENTAL
Intervention: Sumatriptan
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32321763

Group type: EXPERIMENTAL
Intervention: Diet patterns in cases of dementia (n = 209)
Number of subjects: 627

Group type: COMPARATOR
Intervention: Diet patterns in controls (n = 418)
Number of subjects: 627
Study: 35397754

Group type: EXPERIMENTAL
Intervention: INVEST intervention (cognitive-behavioural therapy informed vestibular rehabilitation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Gold standard vestibular rehabilitation (VRT)
Number of subjects: 40
Study: 34167464

Group type: EXPERIMENTAL
Intervention: Knowledge of doctor-patient communication skills
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Practice of doctor-patient communication skills
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Predictors of better practice scores
Number of subjects: 400
Study: 35428690

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nomograms for overall survival
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nomograms for cancer specific death
Number of subjects: 0
Study: 32418846

Group type: EXPERIMENTAL
Intervention: Alpha Lipoic Acid (ALA) 1200 mg daily
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 35842566

Group type: EXPERIMENTAL
Intervention: EOX plus aspirin (150 mg daily)
Number of subjects: 95

Group type: COMPARATOR
Intervention: EOX alone
Number of subjects: 95
Study: 34291796

Group type: EXPERIMENTAL
Intervention: Triple Antibiotic Solution (TAS)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Chlorhexidine Gluconate (CHG)
Number of subjects: 88
Study: 35550060

Group type: EXPERIMENTAL
Intervention: Elotuzumab plus lenalidomide and dexamethasone
Number of subjects: 748

Group type: COMPARATOR
Intervention: Lenalidomide and dexamethasone
Number of subjects: 748
Study: 32027206

Group type: EXPERIMENTAL
Intervention: Visual Art Therapy (VAT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 39
Study: 32754150

Group type: EXPERIMENTAL
Intervention: Micronutrient powder (MNP) with 5 mg iron daily for 4 months starting at age 7.5 months
Number of subjects: 573

Group type: COMPARATOR
Intervention: Micronutrient powder (MNP) without iron
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Hemoglobin at time of vaccination
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Anemia and serum transferrin receptor at time of vaccination
Number of subjects: 573
Study: 36448359

Group type: EXPERIMENTAL
Intervention: Vitality acupunch (VA) exercise program for 6 months
Number of subjects: 103
Study: 35272776

Group type: EXPERIMENTAL
Intervention: Bicuspid aortic stenosis
Number of subjects: 145

Group type: COMPARATOR
Intervention: Tricuspid aortic stenosis
Number of subjects: 145
Study: 32756930

Group type: EXPERIMENTAL
Intervention: Spinal Manipulation
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Spinal Mobilization
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo (Sham Cold Laser Therapy)
Number of subjects: 162
Study: 35526782

Group type: EXPERIMENTAL
Intervention: Amniocentesis
Number of subjects: 397
Study: 34273907

Group type: EXPERIMENTAL
Intervention: Therapists' perceptions based on client vignettes with varying class and race descriptions
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Therapists' confidence in diagnosis
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Diagnostic recommendations based on client vignettes
Number of subjects: 138
Study: 32854842

Group type: EXPERIMENTAL
Intervention: Pulsed Field Ablation (PFA) for pulmonary vein isolation (PVI) and left atrial posterior wall (LAPW) ablation
Number of subjects: 25
Study: 34111810

Group type: EXPERIMENTAL
Intervention: Algorithm combining ICD codes and FVIII/FIX activity <0.4 IU/ml
Number of subjects: 2642
Study: 32093701

Group type: EXPERIMENTAL
Intervention: PUSH notifications from a mobile app for improving body composition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 36001055

Group type: EXPERIMENTAL
Intervention: PEG-rhG-CSF
Number of subjects: 100

Group type: COMPARATOR
Intervention: rhG-CSF
Number of subjects: 100
Study: 34021709

Group type: EXPERIMENTAL
Intervention: F/TAF
Number of subjects: 5387

Group type: COMPARATOR
Intervention: F/TDF
Number of subjects: 5387

Group type: COMPARATOR
Intervention: Counterfactual bHIV
Number of subjects: 5387
Study: 33376301

Group type: EXPERIMENTAL
Intervention: Brexpiprazole
Number of subjects: 0
Study: 33448930

Group type: EXPERIMENTAL
Intervention: On-demand SRH mHealth platform (ARMADILLO)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Proposed enhancements to the platform
Number of subjects: 30
Study: 36084228

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) - supervised progressive total body heavy RT program 2 times per week for 12 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group - instructed to continue their everyday life
Number of subjects: 20
Study: 33047411

Group type: EXPERIMENTAL
Intervention: MAS063DP
Number of subjects: 16

Group type: COMPARATOR
Intervention: white petrolatum
Number of subjects: 16
Study: 35421283

Group type: EXPERIMENTAL
Intervention: CHAIR
Number of subjects: 18

Group type: COMPARATOR
Intervention: LAB
Number of subjects: 18
Study: 33591139

Group type: EXPERIMENTAL
Intervention: Superficial cervical plexus block (CPB)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Combined superficial cervical plexus block and interscalene block (ISB)
Number of subjects: 70
Study: 32936790

Group type: EXPERIMENTAL
Intervention: Rocuronium and Sugammadex (Group RS)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Rocuronium and Neostigmine (Group RN)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Cisatracurium and Neostigmine (Group CN)
Number of subjects: 102
Study: 35351037

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT), one session per week for 3 to 4 months
Number of subjects: 60
Study: 34447583

Group type: EXPERIMENTAL
Intervention: Surfactant + Budesonide
Number of subjects: 128

Group type: COMPARATOR
Intervention: Surfactant
Number of subjects: 128
Study: 35763229

Group type: EXPERIMENTAL
Intervention: Chemoendocrine therapy (CET)
Number of subjects: 13500

Group type: COMPARATOR
Intervention: Endocrine therapy (ET)
Number of subjects: 13500

Group type: EXPERIMENTAL
Intervention: CET
Number of subjects: 13500
Study: 33356994

Group type: EXPERIMENTAL
Intervention: Insulin infusion at 100% of basal rate
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Insulin infusion at 150% of basal rate
Number of subjects: 26

Group type: COMPARATOR
Intervention: Intense exercise compared to moderate exercise
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Insulin infusion rate effect on AUCRd
Number of subjects: 26
Study: 34893041

Group type: EXPERIMENTAL
Intervention: Comprehensive method (n=74)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Group discussion by dentists (n=59)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Face to face education by primary health care providers (n=53)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Social network (n=53)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Control group (n=200)
Number of subjects: 439
Study: 36351459

Group type: EXPERIMENTAL
Intervention: Bivalirudin plus a high-dose infusion for 2-4 hours after PCI
Number of subjects: 6016

Group type: COMPARATOR
Intervention: Heparin monotherapy
Number of subjects: 6016
Study: 33524981

Group type: EXPERIMENTAL
Intervention: Transurethral bipolar plasmakinetic enucleation of the prostate (PKEP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 0
Study: 32294317

Group type: EXPERIMENTAL
Intervention: Logistic clinical SYNTAX score
Number of subjects: 205

Group type: COMPARATOR
Intervention: Anatomical CABG SYNTAX score
Number of subjects: 205
Study: 35083337

Group type: EXPERIMENTAL
Intervention: Exercise training in municipality setting (1 hour, twice weekly for 12 weeks)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Exercise training in hospital setting (1 hour, twice weekly for 12 weeks)
Number of subjects: 72

Group type: COMPARATOR
Intervention: General population (reference data)
Number of subjects: 72
Study: 33313759

Group type: EXPERIMENTAL
Intervention: Systemic inflammatory regulators
Number of subjects: 455258

Group type: COMPARATOR
Intervention: Alzheimer's disease
Number of subjects: 455258
Study: 32250714

Group type: COMPARATOR
Intervention: brodalumab 210 mg every 2 weeks (Q2W)
Number of subjects: 0

Group type: COMPARATOR
Intervention: brodalumab 210 mg Q2W
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ustekinumab
Number of subjects: 0
Study: 34379363

Group type: EXPERIMENTAL
Intervention: Participation in a randomized trial between two types of radiation
Number of subjects: 1046

Group type: EXPERIMENTAL
Intervention: Participation in a randomized trial between two treatment durations
Number of subjects: 1046
Study: 35834861

Group type: EXPERIMENTAL
Intervention: Hyperglycemia on admission (serum glucose >7.8 mmol/L)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Normoglycemic patients (serum glucose ≤7.8 mmol/L)
Number of subjects: 173
Study: 34530433

Group type: EXPERIMENTAL
Intervention: 1-minute interset rest interval (ISRI)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3-minute interset rest interval (ISRI)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1-minute ISRI
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3-minute ISRI
Number of subjects: 10
Study: 33310665

Group type: EXPERIMENTAL
Intervention: Ozonated autohemotherapy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 18
Study: 34172825

Group type: EXPERIMENTAL
Intervention: Combination pill
Number of subjects: 620

Group type: COMPARATOR
Intervention: No contraception
Number of subjects: 620
Study: 32703001

Group type: EXPERIMENTAL
Intervention: Mirror book therapy in conjunction with standard facial rehabilitation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Facial physical rehabilitation without mirror book therapy
Number of subjects: 25
Study: 33269808

Group type: EXPERIMENTAL
Intervention: Modified Prolonged Exposure Therapy (mPE)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard of Care Treatment (SoC)
Number of subjects: 74
Study: 32000725

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) with VR exposure based on 360° videos
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) with in vivo exposure
Number of subjects: 90

Group type: COMPARATOR
Intervention: VR relaxation therapy
Number of subjects: 90
Study: 35412227

Group type: EXPERIMENTAL
Intervention: Treat-and-extend (T&E) regimen
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Pro re nata (PRN) regimen
Number of subjects: 458

Group type: COMPARATOR
Intervention: Fixed dosing regimen
Number of subjects: 458
Study: 34770193

Group type: EXPERIMENTAL
Intervention: OHEMA (Oral Health Education Mobile App)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 32681134

Group type: EXPERIMENTAL
Intervention: Auditory BCI
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tactile BCI
Number of subjects: 20

Group type: COMPARATOR
Intervention: Auditory BCI to Tactile BCI switch
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tactile BCI to Auditory BCI switch
Number of subjects: 20
Study: 37142054

Group type: COMPARATOR
Intervention: Endometrial scratch (not explicitly mentioned as an intervention in this study)
Number of subjects: 40
Study: 33704352

Group type: EXPERIMENTAL
Intervention: Ad26.COV2.S vaccine (5×10^10 or 1×10^11 viral particles)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 32058543

Group type: EXPERIMENTAL
Intervention: Screening mammography
Number of subjects: 0

Group type: COMPARATOR
Intervention: All-cause mortality
Number of subjects: 0
Study: 33587827

Group type: EXPERIMENTAL
Intervention: Youth and family engagement in research and service design
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Facilitators of engagement
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Barriers to engagement
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Overall impact of engagement
Number of subjects: 28
Study: 32648810

Group type: EXPERIMENTAL
Intervention: brexpiprazole 2–4 mg/day
Number of subjects: 1405

Group type: EXPERIMENTAL
Intervention: brexpiprazole 1–4 mg/day
Number of subjects: 1405

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1405
Study: 34735776

Group type: EXPERIMENTAL
Intervention: Partially supervised physical activity intervention (3 hours of vigorous PA per week)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (no change in PA behavior)
Number of subjects: 117
Study: 33713718

Group type: EXPERIMENTAL
Intervention: Combination treatment (MWD + CDO)
Number of subjects: 120

Group type: COMPARATOR
Intervention: MWD
Number of subjects: 120

Group type: COMPARATOR
Intervention: CDO
Number of subjects: 120
Study: 33046070

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP)
Number of subjects: 5852

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) in patients with additional cardiovascular disease (CVD)
Number of subjects: 5852

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) in patients with only the index ACS
Number of subjects: 5852
Study: 35151572

Group type: EXPERIMENTAL
Intervention: Supervised Exercise Therapy (SET)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Endovascular Revascularisation (ER)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: SET
Number of subjects: 240

Group type: COMPARATOR
Intervention: ER
Number of subjects: 240
Study: 33899268

Group type: EXPERIMENTAL
Intervention: Oral prophylaxis with oral hygiene instructions only (test)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Subgingival instrumentation (control)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both interventions (test and control)
Number of subjects: 62
Study: 34911035

Group type: EXPERIMENTAL
Intervention: Sleep Deprivation Training (SDT)
Number of subjects: 1
Study: 35673945

Group type: EXPERIMENTAL
Intervention: Scapular stabilization exercises and postural correction exercises
Number of subjects: 60

Group type: COMPARATOR
Intervention: Postural correctional exercises
Number of subjects: 60
Study: 35184491

Group type: EXPERIMENTAL
Intervention: Four doses of 20 µg vaccination
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Four doses of 60 µg vaccination
Number of subjects: 273

Group type: COMPARATOR
Intervention: Three doses of 20 µg vaccination
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: CKD patients without immune suppression or hormone therapy
Number of subjects: 273
Study: 34782599

Group type: EXPERIMENTAL
Intervention: Surgery plus extensive intraoperative peritoneal lavage (EIPL)
Number of subjects: 662

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 662
Study: 34625003

Group type: EXPERIMENTAL
Intervention: Battlefield acupuncture (BFA)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Routine standard care only (Control)
Number of subjects: 69
Study: 32039879

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS over the contralesional primary motor cortex and iTBS over the ipsilesional M1 (Group A)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Contralesional 1 Hz rTMS and ipsilesional sham iTBS (Group B)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Contralesional sham 1 Hz rTMS and ipsilesional sham iTBS (Group C)
Number of subjects: 28
Study: 35149266

Group type: EXPERIMENTAL
Intervention: autologous mesenchymal stem cells (aMSCs) therapy (n = 9)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo infusion (n = 11)
Number of subjects: 20
Study: 32189096

Group type: EXPERIMENTAL
Intervention: Brief intervention (BI)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 48
Study: 35934778

Group type: EXPERIMENTAL
Intervention: 4 mg pitavastatin
Number of subjects: 12413

Group type: COMPARATOR
Intervention: 1 mg pitavastatin
Number of subjects: 12413
Study: 35152194

Group type: EXPERIMENTAL
Intervention: Licorice mucoadhesive film
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo mucoadhesive film
Number of subjects: 60
Study: 33370131

Group type: EXPERIMENTAL
Intervention: Lower-cost implementation supports (LC)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Expert MATCH consultation plus lower-cost supports (CLC)
Number of subjects: 200
Study: 35287519

Group type: EXPERIMENTAL
Intervention: Criminal context warned feigners
Number of subjects: 145

Group type: COMPARATOR
Intervention: Truth tellers
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Criminal context feigners
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Civil context feigners
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Civil context warned feigners
Number of subjects: 145
Study: 32356559

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Healthy older sedentary individuals (SR)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Healthy older active individuals (HA)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Healthy older sedentary individuals (HS)
Number of subjects: 158
Study: 34038208

Group type: EXPERIMENTAL
Intervention: Participatory continuous nursing using the WeChat platform
Number of subjects: 78

Group type: COMPARATOR
Intervention: Regular care (Control)
Number of subjects: 78
Study: 33177134

Group type: EXPERIMENTAL
Intervention: High-frequency telerehabilitation speech and language therapy (teleSLT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Telerehabilitative cognitive training (teleCT)
Number of subjects: 100
Study: 35059864

Group type: EXPERIMENTAL
Intervention: Bone-modifying agents (BMA)
Number of subjects: 162
Study: 34638428

Group type: EXPERIMENTAL
Intervention: Bright white light intervention (BWL)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Dim white light comparison (DWL)
Number of subjects: 166
Study: 34480887

Group type: EXPERIMENTAL
Intervention: tDCS associated with functional exercise
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham-tDCS associated with functional exercise
Number of subjects: 31
Study: 32957077

Group type: EXPERIMENTAL
Intervention: Traditional group (TRG) - 6 sets × 5 repetitions with 3 minutes of interset rest.
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Rest redistribution group (RRG) - 1 set × 30 repetitions with 31 seconds of interrepetition rest.
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group - no intervention.
Number of subjects: 35
Study: 32147484

Group type: EXPERIMENTAL
Intervention: TDF + pegIFN + REP 2139 or REP 2165
Number of subjects: 40

Group type: COMPARATOR
Intervention: TDF + pegIFN
Number of subjects: 40
Study: 35084526

Group type: EXPERIMENTAL
Intervention: Physiotherapeutic prehabilitation (pERACS)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Normal physical activities (Control)
Number of subjects: 107
Study: 33227448

Group type: COMPARATOR
Intervention: Control RCTs (n = 13, 115, 71, and 36 trials)
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: RCTs with publication integrity concerns (n = 151 and 35 trials)
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Two-arm RCTs with publication integrity concerns
Number of subjects: 373
Study: 32466396

Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 10
Study: 35213721

Group type: EXPERIMENTAL
Intervention: Complete reperfusion after PCI with TFG = 3
Number of subjects: 2606

Group type: EXPERIMENTAL
Intervention: Normal myocardial perfusion with TMPG = 3
Number of subjects: 2606

Group type: EXPERIMENTAL
Intervention: Complete vs. incomplete TFG in STEMI
Number of subjects: 2606

Group type: EXPERIMENTAL
Intervention: Normal vs. abnormal TMPG in NSTE-ACS
Number of subjects: 2606
Study: 34657869

Group type: EXPERIMENTAL
Intervention: Physical Self-Care Support Program (PSCSP)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 45
Study: 32506558

Group type: EXPERIMENTAL
Intervention: QuikFix (individualised personality-specific coping skills training)
Number of subjects: 398

Group type: COMPARATOR
Intervention: MI (motivational interviewing)
Number of subjects: 398

Group type: COMPARATOR
Intervention: AF/I (assessment feedback/information)
Number of subjects: 398
Study: 32331914

Group type: EXPERIMENTAL
Intervention: Injectable antibiotics (primarily penicillins and cephalosporins)
Number of subjects: 5446

Group type: EXPERIMENTAL
Intervention: Third-generation cephalosporins
Number of subjects: 5446

Group type: EXPERIMENTAL
Intervention: Analgesics and insulin
Number of subjects: 5446

Group type: EXPERIMENTAL
Intervention: Cost of prescription and injectable drugs
Number of subjects: 5446
Study: 35447934

Group type: EXPERIMENTAL
Intervention: Freshwater clam extract (FCE), 2 grams daily for 180 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo, 2 grams daily for 180 days
Number of subjects: 36
Study: 34176420

Group type: EXPERIMENTAL
Intervention: Irritable Bowel Syndrome (IBS)
Number of subjects: 360194
Study: 32664101

Group type: EXPERIMENTAL
Intervention: LIA (local infiltration analgesia)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ISB (interscalene nerve block)
Number of subjects: 0
Study: 35710226

Group type: EXPERIMENTAL
Intervention: PILATES (12-week program at moderate intensity, 3x/week, 60-min sessions)
Number of subjects: 22

Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 22